Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

American Well Q3 2026 Results: Net Loss of $11.4M, Loss Narrows

For the quarter ended September 30, 2026, American Well reported revenue of $49.0 million, a decrease from $56.3 million in the prior year period. The company significantly narrowed its net loss to $11.0 million compared to $31.9 million in 2025, driven by substantial reductions in research and development and general and administrative expenses.

Watch the American Well Corp earnings callFull call on the ALFA USA YouTube channel
Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue49.056.3
Profit before tax-10.2-30.7
Net income-11.4-32.4
EPS (diluted, $ a share)$-0.67$-2.00

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year-13.0%
Operating margin-23.8%
Source

10-Q filed with the SEC, NYSE: AMWL. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

American Well Corp: key numbers

Share price
$11.34Close, Nov 16
Sector
Trade & Services
Industry
Services-Business Services, NECSIC 7389

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from American Well Corp

All →
4:13 PM ET 8-K
Financial Results

American Well Financial Results

American Well Corp (Amwell) reported Q3 2026 total revenue of $49.0 million, exceeding its previous guidance, and a net loss of $11.0 million. The company raised its full-year 2026 revenue outlook to a range of $204-$206 million and reiterated its goal to achieve positive cash flow from operations in the fourth quarter of 2026.

Term
Q3 2026

“Health plans and employers want engagement, outcomes and proof, and Amwell’s single platform is built to deliver all three. Across six focus areas that all run on one platform, we are activating more members, simplifying their experience and deepening their relationship with clinicians, giving customers choice without the sprawl, demonstrating outcomes, and using a common data structure to show what works. We expect to generate positive cash flow from operations in the fourth quarter, and we believe we are well positioned to be the trusted platform where AI-powered care runs.”

Dr. Ido Schoenberg, Chairman and CEO of Amwell
5:32 PM ET Form 4
Insider Selling

American Well President, International Phyllis Gotlib Sells $86.8K of Stock

Phyllis Gotlib, President, International, sold 6,677 shares of American Well Corp at $13.00 a share, worth $86.8K in total on Oct 1, 2026. Shares held after the trade: 142,504 (-4.5%).

Value
$86.8K
Shares
6,677
Price
$13.00
Role
President, International
Holding change
-4.5%
Trade date
Oct 1, 2026
5:29 PM ET Form 4
Insider Selling

American Well CFO Mark Hirschhorn Sells $55.7K of Stock

Mark Hirschhorn, CFO, sold 4,282 shares of American Well Corp at $13.00 a share, worth $55.7K in total on Oct 1, 2026. Shares held after the trade: 223,906 (-1.9%).

Value
$55.7K
Shares
4,282
Price
$13.00
Role
CFO
Holding change
-1.9%
Trade date
Oct 1, 2026
5:25 PM ET Form 4
Insider Selling

American Well Chief Product & Tech. Officer Dmitry Zamansky Sells $110K of Stock

Dmitry Zamansky, Chief Product & Tech. Officer, sold 8,442 shares of American Well Corp at $13.00 a share, worth $110K in total on Oct 1, 2026. Shares held after the trade: 224,178 (-3.6%).

Value
$110K
Shares
8,442
Price
$13.00
Role
Chief Product & Tech. Officer
Holding change
-3.6%
Trade date
Oct 1, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.